Odyssey Healthcare — Investor Presentation (May 2007)
34 slides from Odyssey Healthcare's investor presentation, May 22, 2007

Slide 1: To Serve All People During the End of Life's Journey
“To Serve All People During the End of Life’s Journey” HealthCare Odyssey

Slide 2: Forward-Looking Statements
Forward--Looking Statements Certain statements contained in this presentation are forward-looking statements within the meaning of the federal securities laws. Such forward-looking statements are based on management’s current expectations and are subject to known and unknown risks, uncertainties and

Slide 3: Odyssey... A Leader in Hospice Care
Odyssey… A Leader in Hospice Care 80 Medicare Certified Programs in 30 states 33,920 admissions in 2006 CAGR revenue = 25.6% 80 Medicare Certified Programs in 30 states 33,920 admissions in 2006

Slide 4: Investment Highlights
Investment Highlights Favorable growth demographics CMS acknowledges value of industry Experienced management team New growth strategies Strong balance sheet and cash flow

Slide 5: Odyssey Locations
Odyssey Locations Hospice Office Inpatient Facility Corporate Office - Dallas

Slide 6: What is Hospice?
What is Hospice? Provides quality of life for terminal patients and families Focus on physical, emotional and spiritual More cost effective Services provided primarily in home

Slide 7: Four Levels of Care
Four Levels of Care *Per diem rates vary by geographic location Routine $129 per diem* At patient’s residence, including nursing home Approximately 90% of the market $129 per diem* At patient’s residence, including nursing home Approximately 90% of the market continuous $802 per diem* (hourly billin

Slide 8: Covered by Medicare
Covered by Medicare Benefit enacted in 1983 Benefit enacted in 1983 Aggregate per beneficiary cap of $20,585 Aggregate per beneficiary cap of $20,585 Six months life expectancy Six months life expectancy Largest payer at > 90% is Medicare Largest payer at > 90% is Medicare Service promoted by CMS Se

Slide 9: Market Opportunity
Market Opportunity Sudden Death/Other Hospice Patients Served 41% 2.5 million deaths annually in U.S. 42% Under-Served Market 17%

Slide 10: Patients by Diagnosis in the Industry
Patients by Diagnosis in the Industry Heart Disease 12.2% 20% 8.9% 46% 8.2% 3.1% Other Dementia Cancer Lung Disease Kidney Disease Liver Disease 1.6%

Slide 11: Rapidly Growing Market
Rapidly Growing Market Hospice Medicare Expenditures ($ in billions) $2.9 $3.6 $4.5 $5.7 $8.2 FY 2000 FY 2001 FY 2002 FY 2003 FY 2005 $6.9 FY 2004

Slide 12: Hospice Market - Growth Factors
Hospice Market - Growth Factors Increased length of stay Increased penetration - greater understanding and acceptance Additional diagnosis utilizing hospice Aging population

Slide 13: Hospice Market
Hospice Market Non-profit & Government 54% Approximately 2,850 hospice programs in 2005 46% For profit

Slide 14: Hospice Types
Hospice Types SNF-based 1% Home Health-based 23% 19% 57% Hospital-based Free Standing

Slide 15: Strategic Focus
Strategic Focus Service excellence Refine growth strategies Continue development of new inpatient units Balance top line growth with a more disciplined approach to infrastructure and costs

Slide 16: Growth Strategy
Growth Strategy Growth Same store growth De Novos Acquisitions

Slide 17: Same Store Growth
Same Store Growth Expanding continuum of care to increase market share Leverage footprint by opening alternate delivery sites Continue to refine basic sales strategy Same Store Growth

Slide 18: Distribution by Program Size
Distribution by Program Size Q1 2007 0 - 50 51 - 100 101 - 200 201+ Patients Patients Patients Patients # of Programs 18 26 30 6 Avg. Size 31 ADC 76 ADC 140 ADC 250 ADC Avg. Revenue $381,650 $927,266 $1,771,407 $3,208,195 Avg. Net Margin (9.0)% 10.5% 19.7% 28.9%

Slide 19: Criteria for De Novos
Criteria for De Novos Growing markets Broad base of referral sources Competitive advantage Regulatory environment

Slide 20: Acquisitions
Acquisitions Strategic acquisitions Cap management Market entry Market consolidation Strong cash position and balance sheet Disciplined pricing strategy

Slide 21: Medicare "Cap"
Medicare “Cap” Sets a limit on reimbursement per provider number Determined on an annual basis at program level $20,585 x number of adjusted admissions = limit

Slide 22: Medicare Cap Management
Medicare Cap Management Increase short-term admissions Balance mix of patients Manage length of stay Open inpatient units

Slide 23: Medicare Cap Performance
Medicare Cap Performance Level - % of Peak 80 - 100% 50 - 80 % < 50 % % of Cap Limit 80 - 105% 50 - 80% 105 - 115% < 50% > 115% Percentage of Programs 11.3% 37.5% 5.0% 41.2% 5.0%

Slide 24: Inpatient Unit Development
Inpatient Unit Development Two strategies Medicare cap - acute, short stay patients Grow market share - create differentiation Five to six new projects during 2007 Opening losses Pre-opening loss - $400,000 Additional loss before breakeven - $300,000 FY 2007 loss due to new inpatient units = $3,600,

Slide 25: Financial Summary
Financial Summary Odyssey HealthCare

Slide 26: Net Revenue Growth from Continuing Operations
Net Revenue Growth from Continuing Operations CAGR = 25.6% CAGR = 25.6% 2001 $130.2 2002 $194.3 2003 $268.9 2004 $336.7 $407.6 2005 2006 $375.4 $103.4 Q107 $102.6 Q106

Slide 27: Admissions from Continuing Operations
Admissions from Continuing Operations 15,969 2001 21,764 2002 26,458 2003 30,341 2004 33,920 2006 32,857 2005 8,970 Q107 9,046 Q106

Slide 28: Average Length of Stay from Continuing Operations
Average Length of Stay from Continuing Operations Average Length of Stay from Continuing Operations (Days) 2003 74 2004 79 2005 82 2006 86 85 Q107 85 Q106

Slide 29: Average Daily Census from Continuing Operations
Average Daily Census from Continuing Operations 3,044 2001 4,404 2002 5,904 2003 7,314 2004 8,283 2006 7,836 2005 8,261 Q107 8,176 Q106

Slide 30: Income from Continuing Operations
Income from Continuing Operations * Excludes charge for settlement with Department of Justice of $9.6 million, net of tax ** Excludes stock compensation expenses of $3.0 million, Medicare cap adjustments related to prior periods of $2.5 million, severance of $0.2 million and an increase in reserves

Slide 31: Reconciliation of Non-GAAP Financial Measures
Reconciliation of Non-GAAP Financial Measures ($ in millions) Income from continuing operations Add: Government settlement Less: Provision for income taxes Adjusted income from continuing operations Income from continuing operations Add: Stock-based compensation charges Medicare cap adjustment Litig

Slide 32: Net Cash from Continuing Operations
Net Cash from Continuing Operations ($ in millions) * Exclusive of $13 million for Department of Justice payment $27.6 2003 $47.1 2004 2005 $45.6* $47.9* 2006 $14.5* Q106 $1.5 Q107

Slide 33: Investment Highlights
Investment Highlights Favorable growth demographics CMS acknowledges value of industry Experienced management team New growth strategies Strong balance sheet and cash flow

Slide 34: To Serve All People During the End of Life's Journey
“To Serve All People During the End of Life’s Journey” Odyssey HealthCare
Source: SEC EDGAR · 8-K filed May 22, 2007
More decks from Odyssey Healthcare Inc
Investor Presentation (November 2008)36 slides · Nov 4, 2008
Investor Presentation (May 2008)44 slides · May 22, 2008
Q1 2008 Earnings Presentation22 slides · May 15, 2008
Investor Presentation (March 2008)46 slides · Mar 18, 2008
Investor Presentation (February 2008)44 slides · Feb 13, 2008
Investor Presentation (January 2008)43 slides · Jan 10, 2008